Skip to main content
Figure 1 | Allergy, Asthma & Clinical Immunology

Figure 1

From: A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)

Figure 1

Flow diagram of the clinical trial progress. Safety Set (SS): Randomized patients who took at least one dose of the study treatment; Full Analysis Set (FAS): randomized patients who met all selection criteria and had a value of the mini-RQLQ at baseline (visit 1); Per Protocol Set (PPS): FAS patients who completed the study treatment, did not take prohibited medications and who had a value for the primary variable (mini-RQLQ at visit 2).

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us